 |
 |
|||||
|
||||||
|
|
||||||
 |
 |
|||||
|
|
|
|
TRANSAVE ANNOUNCES POSITIVE PHASE II RESULTS FOR ONCE-DAILY ARIKACE™ IN THE TREATMENT OF CYSTIC FIBROSIS PATIENTS WHO HAVE PSEUDOMONAS LUNG INFECTIONS |
||
 |
||
|
|
||
|
|
|
|
|
|||||
|
||||||
|
|
||||||
|
|
|||||
|
|
|
|
TRANSAVE ANNOUNCES POSITIVE PHASE II RESULTS FOR ONCE-DAILY ARIKACE™ IN THE TREATMENT OF CYSTIC FIBROSIS PATIENTS WHO HAVE PSEUDOMONAS LUNG INFECTIONS |
||
|
||
|
|
||
|
|
|